4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-086747
Options or other derivatives
- President and CEO acquired 149,035 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Walker Neal President and CEO | 2015-12-18 | Grant or award · Stock option (right to buy) | +137,335 | 137,335 | D | ||
| Walker Neal President and CEO | 2015-12-18 | Grant or award · Restricted stock units | +11,700 | 11,700 | D | ||
Loading xslF345X03/doc4.xml…